Onco-Nephrology Fellowship
Our Onco-nephrology fellowship is a comprehensive academic training program designed to prepare physicians for successful careers in academic onco-nephrology. The program begins annually on July 1 and consists of one year of combined clinical and research training. An optional second year focused on research may be offered on a case-by-case basis following discussion with the program director and fellowship leadership. Fellows are expected to dedicate the majority of their time to developing advanced clinical expertise and pursuing scholarly activities that support their long-term academic career goals.
During the fellowship, trainees rotate through specialized inpatient and outpatient nephrology services with a focus on the care of patients with cancer-related kidney disease. Protected academic time is provided for research activities and elective rotations. Fellows are expected to develop expertise in the diagnosis and management of complex renal complications in patients with cancer, including chemotherapy-associated kidney injury, electrolyte and acid-base disorders, glomerular diseases and other oncologic nephrology conditions.
A key component of the program is the development and execution of research projects arising from clinically relevant, hypothesis-driven questions. Fellows are expected to complete scholarly work that leads to presentations at regional and national meetings and publications in peer-reviewed journals.
In addition, fellows actively participate in and present at journal club and research conferences. Attendance is expected at institutional grand rounds, nephrology division conferences, and other educational lectures, seminars and courses relevant to their clinical and academic development.
Letter from our Program Directors
Why UT MD Anderson is the Premier Destination for Onco-Nephrology Training
If you want to master the field of onco-nephrology, UT MD Anderson is undoubtedly one of the best places to train. Here, you’ll encounter patients with cancer—not just the common types but also rare and complex malignancies. As the largest cancer center in the world, we provide unparalleled exposure to the entire spectrum of onco-nephrology, including rare and atypical presentations.
Immersive, Inpatient-Focused Training
Your training will primarily revolve around inpatient care. While this can be more demanding than an outpatient-based experience, it is also far more rewarding in terms of learning opportunities. Inpatient care offers immediate and rich feedback, enabling you to sharpen your diagnostic skills and clinical judgment. You will have the chance to witness the broad repertoire of kidney-related complications in cancer patients.
UT MD Anderson provides a unique opportunity to refine your differential diagnosis skills and to test and implement various treatment strategies, learning in real time what works. The process is akin to the “10,000 hours” principle of achieving mastery, with the critical addition of consistent feedback to augment your expertise. Throughout this journey, you will be guided by attending physicians, some of whom have been leaders in onco-nephrology for over a decade.
Mastering the Language of Oncology
One of the most valuable aspects of training at UT MD Anderson is the opportunity to learn the language of oncologists. Oncologists often use specialized jargon and shorthand, which can initially seem foreign. You'll gradually become fluent in this terminology by systematically looking up every cancer type, chemotherapy acronym, and targeted therapy protocol. This fluency will enhance your ability to collaborate with oncologists and improve your communication with patients, empowering you to explain their conditions and treatments more effectively.
As an Onco-Nephrologist, you will gain cross-disciplinary knowledge that will enable you to recognize and recall key oncology regimens plus their nephrotoxicity’s, making you an indispensable part of the care team.
Expanding Your Horizons Through External Rotations and Research
Your training will be further enriched by rotations with the myeloma, melanoma, and urology services. Additionally, you will have the flexibility to tailor your own learning by shadowing other cancer specialties, as previous Onco-Nephrology fellows have done. Didactic conferences, designed to challenge and stimulate your intellect, will offer case-based learning and deep dives into pathophysiology.
Moreover, you’ll have protected time to engage in clinical or basic research. With countless unanswered questions and hypotheses to explore, you will have the potential to contribute to the growing body of knowledge in onco-nephrology.
A UT MD Anderson Onco-Nephrology Fellowship certificate will signify your proficiency and open doors to academic and professional opportunities worldwide.
Current Fellow
Esraa Elsammy, M.D.
Esraa Elsamny, M.D., is an onco-nephrology fellow at UT MD Anderson, having completed her pediatric residency and pediatric nephrology fellowship at UTHealth Houston. Originally from Alexandria, Egypt, her clinical focus centers on optimizing renal outcomes and providing comprehensive care for young oncology patients. She is deeply passionate about caring for children with cancer and advancing the field of pediatric onco-nephrology. Outside of her clinical practice, she is the proud mother of two wonderful girls who inspire her daily.
Mohammad Ansari, M.D.
Mohammad Ansari, M.D., hails from Karachi, Pakistan where he went to the prestigious Aga Khan University for his medical school. He did his Internal Medicine residency at Louisiana State University in Shreveport before pursuing his Nephrology Fellowship at UTHealth Houston. His interests include Chronic Kidney Diseases and IgA Nephropathy. He aims to run his own IgA and Onconephrology clinic in the community in the near future.
Alumni
Ahmad Al Masry, M.D.
2025-2026
Juan Jose Cintrón-García, M.D.
2024-2025
Nada Youssef, M.D.
2024-2025
Kiran Shivaraj, M.B.B.S.
2023-2024
Ana-Eve Turcotte, M.D.
2021-2022
Praveen Ratanasrimetha, M.D.
2021-2022
Harini Bejjanki, M.D.
2020-2021
Omar Mamlouk, M.B.B.S.
2019-2020
Jamie Lin, M.D.
2017-2019
Umut Selamet, M.D.
2016-2017
Jaya Kala, M.D.
2015-2016
Charles Minn, M.D.
2014 - 2015
Contact Information
Sheldon Chen, M.D., Professor
Onco-nephrology Fellowship Director
Nada Youseff, M.D., Assistant Professor
Onco-nephrology Assistant Fellowship Director
Lauren Sutton
Program Director
Related Resources
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.
Our Labs
Learn more about our faculty and research taking place in our labs.
Conferences
View conferences available for continuing education credit.